Maternus-Kliniken Aktiengesellschaft (ETR:MAK)

ETR:MAK Statistics

Total Valuation

ETR:MAK has a market cap or net worth of EUR 21.18 million. The enterprise value is 134.42 million.

Market Cap	21.18M
Enterprise Value	134.42M

Important Dates

The next estimated earnings date is Monday, June 1, 2026.

Earnings Date	Jun 1, 2026
Ex-Dividend Date	n/a

Share Statistics

ETR:MAK has 20.97 million shares outstanding.

Current Share Class	20.97M
Shares Outstanding	20.97M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	n/a
Float	3.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.18
PB Ratio	-0.27
P/TBV Ratio	n/a
P/FCF Ratio	1.90
P/OCF Ratio	1.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.88, with an EV/FCF ratio of 12.04.

EV / Earnings	-9.70
EV / Sales	1.14
EV / EBITDA	28.88
EV / EBIT	n/a
EV / FCF	12.04

Financial Position

The company has a current ratio of 0.21

Current Ratio	0.21
Quick Ratio	0.18
Debt / Equity	n/a
Debt / EBITDA	24.94
Debt / FCF	10.40
Interest Coverage	-0.52

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1.80%
Return on Invested Capital (ROIC)	-12.75%
Return on Capital Employed (ROCE)	-7.45%
Weighted Average Cost of Capital (WACC)	5.35%
Revenue Per Employee	63,151
Profits Per Employee	-7,411
Employee Count	1,591
Asset Turnover	0.81
Inventory Turnover	234.96

Taxes

In the past 12 months, ETR:MAK has paid 1.10 million in taxes.

Income Tax	1.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.26% in the last 52 weeks. The beta is 0.09, so ETR:MAK's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-35.26%
50-Day Moving Average	1.15
200-Day Moving Average	1.08
Relative Strength Index (RSI)	47.68
Average Volume (20 Days)	633

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:MAK had revenue of EUR 118.03 million and -13.85 million in losses. Loss per share was -0.66.

Revenue	118.03M
Gross Profit	22.17M
Operating Income	-4.16M
Pretax Income	-12.87M
Net Income	-13.85M
EBITDA	-1.04M
EBIT	-4.16M
Loss Per Share	-0.66

Balance Sheet

The company has 4.29 million in cash and 116.05 million in debt, with a net cash position of -111.76 million or -5.33 per share.

Cash & Cash Equivalents	4.29M
Total Debt	116.05M
Net Cash	-111.76M
Net Cash Per Share	-5.33
Equity (Book Value)	-79.11M
Book Value Per Share	-3.84
Working Capital	-74.40M

Cash Flow

In the last 12 months, operating cash flow was 14.03 million and capital expenditures -2.87 million, giving a free cash flow of 11.16 million.

Operating Cash Flow	14.03M
Capital Expenditures	-2.87M
Depreciation & Amortization	3.13M
Net Borrowing	-5.60M
Free Cash Flow	11.16M
FCF Per Share	0.53

Margins

Gross margin is 18.78%, with operating and profit margins of -3.53% and -11.74%.

Gross Margin	18.78%
Operating Margin	-3.53%
Pretax Margin	-10.90%
Profit Margin	-11.74%
EBITDA Margin	-0.88%
EBIT Margin	-3.53%
FCF Margin	9.46%

Dividends & Yields

ETR:MAK does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-65.40%
FCF Yield	52.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 1, 1996. It was a forward split with a ratio of 20.

Last Split Date	Oct 1, 1996
Split Type	Forward
Split Ratio	20

Scores

ETR:MAK has an Altman Z-Score of -1.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.1
Piotroski F-Score	3